Labcorp Holdings Total Liabilities increased by 6.0% to $10.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.4%, from $9.28B to $10.34B. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows relatively stable performance with a -1.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Used across all industries to assess the overall debt burden relative to equity and assets.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.15B | $10.32B | $10.09B | $9.99B | $9.98B | $9.71B | $10.04B | $9.84B | $8.91B | $8.99B | $8.83B | $8.56B | $8.69B | $10.43B | $10.31B | $9.28B | $9.57B | $9.55B | $9.76B | $10.34B |
| QoQ Change | — | +1.7% | -2.2% | -1.0% | -0.0% | -2.7% | +3.3% | -2.0% | -9.4% | +0.9% | -1.8% | -3.2% | +1.6% | +20.0% | -1.1% | -10.0% | +3.1% | -0.2% | +2.2% | +6.0% |
| YoY Change | — | — | — | — | -1.7% | -5.9% | -0.5% | -1.5% | -10.7% | -7.4% | -12.0% | -13.0% | -2.5% | +15.9% | +16.7% | +8.5% | +10.1% | -8.4% | -5.4% | +11.4% |